Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Alopecia areata involves unique activation of certain immune cells.

New therapies for alopecia areata show potential but need more research.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Inflammation damages sweat ducts, causing sweat gland injury.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Some eczema treatments may cause conjunctivitis, many people have sensitive eyes, air pollution can increase skin wrinkles, hair loss medication does not affect sexual function, and dermatologists can help identify torture signs on refugees' skin.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

VYC-15L is a safe and effective lip filler that lasts up to a year.

Claudin-1 is important for the barrier function and growth of hair.

Bimatoprost gel makes eyelashes grow longer, but may cause side effects and should be monitored by an eye doctor.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Some men lost hair after deoxycholic acid treatment for neck fat, but most saw improvement or resolution.

Men are getting more facial fillers, and doctors should use different techniques and fillers for men's unique facial features to get natural results.

Men need higher doses and tailored injection techniques for botulinum toxin treatments due to their unique facial features.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Entrepreneurial companies are key to advancing dermatology treatments and patient care.